Stay updated on Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial
Sign up to get notified when there's something new on the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page.

Latest updates to the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page
- Check2 days agoChange DetectedA new revision entry (v3.3.4) was added to the record history, and the previous revision (v3.3.3) was removed.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a site revision note: Revision: v3.3.3, and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer. These are administrative updates and do not alter study data or page content.SummaryDifference0.2%

- Check52 days agoChange DetectedThis change only notes minor version updates in the record history (Revision: v3.3.2 added and v3.2.0 removed) and does not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page no longer displays the site-wide notice about government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check81 days agoChange DetectedLatest version adds updates to Recruitment Status and Study Status in the record history for NCT04107727, reflecting changes in the trial's current activity. These updates are part of the core information presented on the study page.SummaryDifference0.1%

- Check103 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 revision tag.SummaryDifference12%

Stay in the know with updates to Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page.